{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:20:35Z","timestamp":1787160035032,"version":"build-2736575974"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.blre.2014.12.001","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T11:03:51Z","timestamp":1418468631000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?"],"prefix":"10.1016","volume":"29","author":[{"given":"Shen-Miao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Peter","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2014.12.001_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1182\/blood.V33.1.79.79","article-title":"Chronic lymphocytic leukemia in Hiroshima and Nagasaki, Japan","volume":"33","author":"Finch","year":"1969","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ajh.2830250317","article-title":"Chronic lymphocytic leukemia in China","volume":"25","author":"Boggs","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Chihara","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0020","series-title":"SEER cancer statistics review","author":"Howlader","year":"1975"},{"key":"10.1016\/j.blre.2014.12.001_bb0025","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ajh.21824","article-title":"Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification","volume":"85","author":"Yoon","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0030","first-page":"65","article-title":"Incidence survey of leukemia in China","volume":"6","author":"Yang","year":"1991","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.blre.2014.12.001_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0145-2126(00)00038-2","article-title":"Decreased chronic lymphocytic leukemia incidence in Asians in Los Angeles County","volume":"24","author":"Gale","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0040","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/10428194.2013.827785","article-title":"Preservation of lower incidence of chronic lymphocytic leukemia in Chinese residents in British Columbia: a 26-year survey from 1983 to 2008","volume":"55","author":"Mak","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0045","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.ejca.2010.07.050","article-title":"Cancer risk diversity in non-western migrants to Europe: an overview of the literature","volume":"46","author":"Arnold","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.blre.2014.12.001_bb0050","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/cas.12192","article-title":"High levels of CD20 expression predict good prognosis in chronic lymphocytic leukemia","volume":"104","author":"Fang","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.blre.2014.12.001_bb0055","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/10428194.2010.531411","article-title":"TOSO is overexpressed and correlated with disease progression in Chinese patients with chronic lymphocytic leukemia","volume":"52","author":"Yi","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0060","first-page":"2417","article-title":"Cytogenetic characteristics of B cell chronic lymphocytic leukemia in 275 Chinese patients by fluorescence in situ hybridization: a multicenter study","volume":"16","author":"Lai","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.blre.2014.12.001_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0609.2010.01518.x","article-title":"Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong","volume":"85","author":"Lan","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.leukres.2005.07.007","article-title":"Distinctive immunoglobulin VH gene usage in Japanese patients with chronic lymphocytic leukemia","volume":"30","author":"Koiso","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2008.07226.x","article-title":"South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients","volume":"142","author":"Gunawardana","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0080","doi-asserted-by":"crossref","first-page":"e62930","DOI":"10.1371\/journal.pone.0062930","article-title":"Improving but inferior survival in patients with chronic lymphocytic leukemia in Taiwan: a population-based study, 1990\u20132004","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2014.12.001_bb0085","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3109\/10428194.2010.527403","article-title":"Chronic lymphocytic leukemia in a Japanese population: varied immunophenotypic profile, distinctive usage of frequently mutated IGH gene, and indolent clinical behavior","volume":"51","author":"Tomomatsu","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12185-013-1286-z","article-title":"Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior","volume":"97","author":"Jang","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","article-title":"Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b)","volume":"108","author":"Moreau","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0609.1998.tb00995.x","article-title":"Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins","volume":"60","author":"Molica","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0105","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3109\/10428194.2013.867486","article-title":"Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia","volume":"55","author":"Huang","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0110","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.leukres.2008.06.026","article-title":"CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia","volume":"33","author":"Xu","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0125","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1007\/s12032-011-0054-2","article-title":"Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide","volume":"29","author":"Xu","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0740","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"26","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergencyto.2004.08.012","article-title":"The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia","volume":"158","author":"Glassman","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.blre.2014.12.001_bb0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1309\/21TN2RUWKR827UW2","article-title":"Chronic lymphocytic leukemia FISH panel: impact on diagnosis","volume":"128","author":"Nelson","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0140","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1080\/10428190802308710","article-title":"Cytogenetic characterisation in Chinese patients with chronic lymphocytic leukemia: a prospective, multicenter study on 143 cases analysed with interphase fluorescence in situ hybridisation","volume":"49","author":"Qiu","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00277-013-1700-x","article-title":"Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence\u2014clinical implication and comparison between the West and the East","volume":"92","author":"Wu","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hon.2103","article-title":"Validation of Western common recurrent chromosomal aberrations in Korean chronic lymphocytic leukaemia patients with very low incidence","volume":"32","author":"Yoon","year":"2014","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.leu.2403242","article-title":"Chronic lymphocytic leukemia with 6q\u2212 shows distinct hematological features and intermediate prognosis","volume":"18","author":"Cuneo","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10428194.2010.542599","article-title":"Intermediate prognosis of 6q deletion in chronic lymphocytic leukemia","volume":"52","author":"Wang","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3892\/ijo.2013.1966","article-title":"Genetic differences between Asian and Caucasian chronic lymphocytic leukemia","volume":"43","author":"Kawamata","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/10428190500287828","article-title":"Comparative genomic hybridization analysis of Japanese B-cell chronic lymphocytic leukemia: correlation with clinical course","volume":"47","author":"Tsukasaki","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0175","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0180","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.leukres.2008.02.005","article-title":"Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia","volume":"32","author":"Chen","year":"2008","journal-title":"Leuk Res"},{"issue":"s1","key":"10.1016\/j.blre.2014.12.001_bb0185","first-page":"44","article-title":"Analysis of immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia","volume":"99","author":"Marinelli","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.12.001_bb0190","first-page":"1259","article-title":"V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia","volume":"88","author":"Duke","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.12.001_bb0195","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2003-10-3407","article-title":"The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process","volume":"103","author":"Messmer","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0200","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/j.1349-7006.2009.01341.x","article-title":"Immunoglobulin heavy chain variable region gene usage and mutational status of the leukemic B cells in Iranian patients with chronic lymphocytic leukemia","volume":"100","author":"Hojjat-Farsangi","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.blre.2014.12.001_bb0205","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","article-title":"Chronic lymphocytic leukemias utilizing the VH3\u201321 gene display highly restricted V 2\u201314 gene use and homologous CDR3s: implicating recognition of a common antigen epitope","volume":"101","author":"Tobin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0210","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V99.6.2262","article-title":"Somatically mutated Ig VH3\u201321 genes characterize a new subset of chronic lymphocytic leukemia","volume":"99","author":"Tobin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0215","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3\u201321 gene","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0220","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.pdm.0000213469.85301.d6","article-title":"Pattern and distribution of immunoglobulin VH gene usage in a cohort of B-CLL patients from a Northeastern region of Italy","volume":"15","author":"Donisi","year":"2006","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0225","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1016\/S2352-3026(14)00005-2","article-title":"Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study","volume":"1","author":"Baliakas","year":"2014","journal-title":"Lancet Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0230","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.humimm.2008.07.015","article-title":"Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia","volume":"69","author":"Hojjat-Farsangi","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.blre.2014.12.001_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.humimm.2013.11.003","article-title":"Frequency analysis of HLA class I alleles in Iranian patients with progressive and non-progressive chronic lymphocytic leukemia","volume":"75","author":"Hojjat-Farsangi","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.blre.2014.12.001_bb0240","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1182\/blood.V122.21.1620.1620","article-title":"HLA is a determinant of the ethnic predisposition of chronic lymphocytic leukemia","volume":"122","author":"Gragert","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1179\/102453309X385197","article-title":"HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?","volume":"14","author":"Erikci","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.blre.2014.12.001_bb0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2013.095281","article-title":"HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism","volume":"99","author":"Rizzo","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.12.001_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1744-313X.2011.01053.x","article-title":"Allele frequencies of human leukocyte antigen-G in a Korean population","volume":"39","author":"Park","year":"2012","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.blre.2014.12.001_bb0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1744-313X.2012.01137.x","article-title":"Distribution of HLA-G 14-bp insertion\/deletion polymorphism in six Chinese ethnic groups","volume":"40","author":"Tao","year":"2013","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.blre.2014.12.001_bb0265","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/leu.2008.379","article-title":"Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors","volume":"23","author":"Kostareli","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0270","first-page":"197","article-title":"Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective analysis of 184 cases","volume":"23","author":"Sriphatphiriyakun","year":"2005","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.blre.2014.12.001_bb0275","first-page":"3","article-title":"Efficacy of chemoimmunotherapy with fludarabine, cyclophosphamide and rituximab for chronic lymphocytic leukemia","volume":"32","author":"Fang","year":"2011","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.blre.2014.12.001_bb0280","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"376","author":"Hallek","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.12.001_bb0285","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/10428190903111930","article-title":"The negative prognostic significance of positive direct antiglobulin test in Chinese patients with chronic lymphocytic leukemia","volume":"50","author":"Xu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0290","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.leukres.2010.12.005","article-title":"Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia","volume":"35","author":"Xu","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0295","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1309\/AJCPHMYT93HUIZKW","article-title":"High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia","volume":"134","author":"Konoplev","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12185-009-0380-8","article-title":"Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors","volume":"90","author":"Xu","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0305","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"Heintel","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0310","first-page":"56","article-title":"The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia","volume":"91","author":"Van'T Veer","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/10428190500464161","article-title":"Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia","volume":"47","author":"N\u00fcckel","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0320","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2004-08-3344","article-title":"The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia","volume":"106","author":"Oppezzo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0325","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1751-553X.2008.01078.x","article-title":"Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors","volume":"31","author":"Xu","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0330","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/leu.2013.263","article-title":"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1; FBXW7; MYD88; XPO1 and TP53 in 1160 untreated CLL patients","volume":"28","author":"Jeromin","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2014.12.001_bb0340","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.blre.2014.12.001_bb0350","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"Zenz","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0355","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1182\/blood-2009-07-234708","article-title":"Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage","volume":"114","author":"Malcikova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/leu.2008.274","article-title":"The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype","volume":"23","author":"Dicker","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0365","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1200\/JCO.2010.32.0838","article-title":"Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial","volume":"29","author":"Gonzalez","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0370","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"Zenz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0375","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1182\/blood-2009-05-224071","volume":"114","author":"Zenz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0380","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2013-03-488197","article-title":"NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG","volume":"122","author":"Schnaiter","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0385","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00277-010-1125-8","article-title":"The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13)","volume":"90","author":"Dong","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0390","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12032-014-0908-5","article-title":"TP53 Pro72 allele potentially increases the poor prognostic significance of TP53 mutation in chronic lymphocytic leukemia","volume":"4","author":"Dong","year":"2014","journal-title":"Med Oncol"},{"issue":"s1","key":"10.1016\/j.blre.2014.12.001_bb0395","first-page":"61","article-title":"Novel gene mutations in Chinese chronic lymphocytic leukemia patients","volume":"99","author":"Xia","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2014.12.001_bb0400","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","author":"Baliakas","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0405","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1182\/blood-2013-10-534271","article-title":"Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness","volume":"123","author":"Messina","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0410","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"21","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0745","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med."},{"key":"10.1016\/j.blre.2014.12.001_bb0420","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00277-013-1883-1","article-title":"Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia","volume":"93","author":"Zhu","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0425","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1080\/10428190701534416","article-title":"The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia","volume":"48","author":"Chen","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0430","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/jcp.2005.035089","article-title":"Methylation of INK4 and CIP\/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patients","volume":"59","author":"Chim","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0435","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/jcp.2008.060152","article-title":"Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia","volume":"61","author":"Chim","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.blre.2014.12.001_bb0440","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/leu.2011.357","article-title":"Dysregulation of TNF\u03b1-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2014.12.001_bb0445","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/10428194.2013.809077","article-title":"Clinical significance of down-regulated cylindromatosis gene in chronic lymphocytic leukemia","volume":"55","author":"Wu","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00109-013-1081-6","article-title":"RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow","volume":"92","author":"Xu","year":"2014","journal-title":"J Mol Med (Berlin)"},{"key":"10.1016\/j.blre.2014.12.001_bb0455","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2407-12-138","article-title":"Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiarity by site","volume":"12","author":"Albright","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.blre.2014.12.001_bb0460","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ng.2652","article-title":"Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2014.12.001_bb0465","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2010-09-308205","article-title":"Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL","volume":"117","author":"Slager","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0470","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2012-03-413591","article-title":"Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia","volume":"120","author":"Slager","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0475","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/bjh.12070","article-title":"Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes","volume":"159","author":"Slager","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0750","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.510","article-title":"Common variants at 2q37.3; 8q24.21; 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk","volume":"42","author":"Crowther-Swanepoel","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2014.12.001_bb0480","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bjh.12366","article-title":"rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?","volume":"162","author":"Sava","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0755","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0609.2010.01518.x","article-title":"Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong","volume":"85","author":"Lan","year":"2010","journal-title":"Eur J Haemato"},{"key":"10.1016\/j.blre.2014.12.001_bb0490","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1182\/blood-2010-05-285221","article-title":"The incidence of chronic lymphocytic leukemia in Taiwan, 1986\u20132005: a distinct increasing trend with birth-cohort effect","volume":"116","author":"Wu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0495","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/epi.23439","article-title":"Uncovering the DNA methylome in chronic lymphocytic leukemia","volume":"8","author":"Cahill","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.blre.2014.12.001_bb0500","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","article-title":"Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia","volume":"129","author":"Raval","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.blre.2014.12.001_bb0505","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0609.2010.01470.x","article-title":"MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia","volume":"85","author":"Willander","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0510","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/ijc.26222","article-title":"MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL","volume":"130","author":"Dong","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.12.001_bb0515","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3109\/10428194.2011.642303","article-title":"MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia","volume":"53","author":"Zhou","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0520","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.blre.2014.12.001_bb0525","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3109\/10428194.2013.855308","article-title":"miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia","volume":"55","author":"Zhou","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2014.12.001_bb0530","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1476-4598-12-173","article-title":"Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia\u2014implications on constitutive activation of NFkappaB pathway","volume":"12","author":"Wang","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.blre.2014.12.001_bb0535","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-12-0803","article-title":"Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia","volume":"72","author":"Baer","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0540","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hon.2900070305","article-title":"Malignant lymphoma in Hawaii-Japanese: a retrospective morphologic survey","volume":"7","author":"Yanagihara","year":"1989","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.blre.2014.12.001_bb0545","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.5790514.x","article-title":"Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan","volume":"67","author":"Tamura","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12185-008-0132-1","article-title":"A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai","volume":"88","author":"Gross","year":"2008","journal-title":"China Int J Hematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0555","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/1055-9965.EPI-11-0038","article-title":"Lymphoid malignancies in US Asians: incidence rate differences by birthplace and acculturation","volume":"20","author":"Clarke","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.12.001_bb0560","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/oxfordjournals.aje.a116362","article-title":"Smoking and risk of leukemia","volume":"135","author":"Brown","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2014.12.001_bb0565","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/01.ede.0000173039.79207.80","article-title":"Canadian Cancer Registries Epidemiology Research Group Environmental tobacco smoke and risk of adult leukemia","volume":"16","author":"Kasim","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.blre.2014.12.001_bb0570","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/oem.2009.046839","article-title":"Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case\u2013control study","volume":"67","author":"Cocco","year":"2010","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0575","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajim.20592","article-title":"Risk of leukemia and multiple myeloma associated with exposure to benzene and other organic solvents: evidence from the Italian Multicenter Case\u2013control study","volume":"51","author":"Costantini","year":"2008","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0580","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1289\/ehp.1002318","article-title":"Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions","volume":"119","author":"Vlaanderen","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.blre.2014.12.001_bb0585","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajim.4700050307","article-title":"An evaluation of the associations of leukemia and rubber industry solvent exposures","volume":"5","author":"Checkoway","year":"1984","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0590","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.leukres.2007.08.015","article-title":"Have we been wrong about ionizing radiation and chronic lymphocytic leukemia?","volume":"32","author":"Hamblin","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0595","series-title":"Committee to review the health effects in Vietnam veterans of exposure to herbicides ninth biennial update BOTH","year":"2014"},{"key":"10.1016\/j.blre.2014.12.001_bb0600","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/aje\/kwr127","article-title":"Cigarette smoking, passive smoking, and non-Hodgkin lymphoma risk: evidence from the California Teachers Study","volume":"174","author":"Lu","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.blre.2014.12.001_bb0605","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/01.ede.0000173039.79207.80","article-title":"Cancer Registries Epidemiology Research Group. Environmental tobacco smoke and risk of adult leukemia","volume":"16","author":"Kasim","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.blre.2014.12.001_bb0735","first-page":"898","article-title":"Mortality in Iowa farmers and farm laborers, 1971\u20131978","volume":"24","author":"Burmeister","year":"1982","journal-title":"J Occup Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0610","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2105\/AJPH.87.1.71","article-title":"Mortality and cancer incidence among sawmill workers exposed to chlorophenate wood preservatives","volume":"87","author":"Hertzman","year":"1997","journal-title":"Am J Public Health"},{"key":"10.1016\/j.blre.2014.12.001_bb0615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3961\/jpmph.2013.46.5.213","article-title":"Agent orange exposure and prevalence of self-reported diseases in Korean Vietnam veterans","volume":"46","author":"Yi","year":"2013","journal-title":"J Prev Med Public Health"},{"key":"10.1016\/j.blre.2014.12.001_bb0620","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2009.10.016","article-title":"A hospital-based case\u2013control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification","volume":"184","author":"Wong","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.blre.2014.12.001_bb0625","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1196\/annals.1454.034","article-title":"Study of the current status and factors that influence indoor air pollution in 138 houses in the urban area in Xi'an","volume":"1140","author":"Liu","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2014.12.001_bb0630","first-page":"473","article-title":"Cao Z","volume":"36","author":"Xu","year":"2007","journal-title":"Wei Sheng Yan Jiu"},{"key":"10.1016\/j.blre.2014.12.001_bb0635","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00128-013-1129-x","article-title":"Characterization and risk assessment of exposure to volatile organic compounds in apartment buildings in Harbin China","volume":"92","author":"Zhu","year":"2014","journal-title":"Bull Environ Contam Toxicol"},{"key":"10.1016\/j.blre.2014.12.001_bb0640","series-title":"Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2","author":"NRC","year":"2005"},{"key":"10.1016\/j.blre.2014.12.001_bb0645","series-title":"Sources and Effects of Ionizing Radiation","article-title":"Epidemiological evaluation of radiation-induced cancer. Annex I","author":"UNSCEAR UNSC","year":"2000"},{"key":"10.1016\/j.blre.2014.12.001_bb0650","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","article-title":"Cancer incidence in atomic bomb survivors. Part III. Leukemia; lymphoma and multiple myeloma; 1950\u20131987","volume":"137","author":"Preston","year":"1994","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0655","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950\u20132001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0660","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.leukres.2007.08.013","article-title":"Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident\u2014with focus on immunoglobulin heavy chain gene analysis","volume":"32","author":"Abramenko","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0665","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10552-007-9048-y","article-title":"Chronic lymphocytic leukemia radiogenicity: a systematic review","volume":"18","author":"Silver","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.blre.2014.12.001_bb0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.envres.2014.01.002","article-title":"Leukemia, lymphoma and multiple myeloma mortality (1950\u20131999) and incidence (1969\u20131999) in the Eldorado uranium workers cohort","volume":"130","author":"Zablotska","year":"2014","journal-title":"Environ Res"},{"key":"10.1016\/j.blre.2014.12.001_bb0675","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1182\/blood-2010-07-295097","article-title":"Cytokine polymorphisms in Th1\/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma","volume":"117","author":"Chen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2014.12.001_bb0680","first-page":"136","article-title":"Comparison of methods for determining occupational exposure in a case\u2013control interview study of chronic lymphocytic leukemia","volume":"29","author":"Linet","year":"1987","journal-title":"J Occup Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0685","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies","volume":"122","author":"Larsson","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.blre.2014.12.001_bb0690","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"W.H.O. Expert Consultation.","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2014.12.001_bb0695","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1158\/1055-9965.EPI-10-0585","article-title":"Dietary factors and risk of chronic lymphocytic leukemia and small lymphocytic lymphoma: a pooled analysis of two prospective studies","volume":"19","author":"Tsai","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.blre.2014.12.001_bb0730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jncimonographs\/lgu001","article-title":"Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia\/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","author":"Slager","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.blre.2014.12.001_bb0760","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1128\/JVI.00163-08","article-title":"Interferon regulatory factor 4 is involved in Epstein\u2013Barr virus-mediated transformation of human B lymphocytes","volume":"82","author":"Xu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.blre.2014.12.001_bb0705","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1128\/JVI.76.21.11133-11138.2002","article-title":"Implication of the lymphocyte-specific nuclear body protein SP140 in an innate response to human immunodeficiency virus type 1","volume":"76","author":"Madani","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.blre.2014.12.001_bb0710","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2014.12.001_bb0715","first-page":"257517","article-title":"Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia","volume":"2014","author":"Gonz\u00e1lez-Gasc\u00f3n","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.blre.2014.12.001_bb0720","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","article-title":"Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study","volume":"144","author":"Bomben","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2014.12.001_bb0725","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10428190601043310","article-title":"Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia","volume":"48","author":"Farsangi","year":"2007","journal-title":"Leuk Lymphoma"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1400099X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X1400099X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T17:46:13Z","timestamp":1717609573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X1400099X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0268960X1400099X"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2014.12.001","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2014.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}